These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9543905)

  • 1. Teaching program effects on high phosphorus levels in patients receiving hemodialysis.
    Schlatter S; Ferrans CE
    ANNA J; 1998 Feb; 25(1):31-6; discussion 37-8. PubMed ID: 9543905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 3. Target levels for serum phosphorus and parathyroid hormone.
    Qunibi W; Kalantar-Zadeh K
    Semin Dial; 2011; 24(1):29-33. PubMed ID: 21324001
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreasing the complications of renal osteodystrophy secondary to high phosphorus levels by using an innovative self-monitoring educational program.
    Zagaroli AM; Zimmer SM; Bowes JM; Hartley KS
    Adv Perit Dial; 1995; 11():254-7. PubMed ID: 8534717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal osteodystrophy in CAPD patients.
    Zucchelli P; Catizone L; Casanova S; Fusaroli M; Fabbri L; Ferrari G
    Miner Electrolyte Metab; 1984; 10(5):326-32. PubMed ID: 6493161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aggressive osteodystrophy management on clinical outcomes in stage 5 chronic kidney disease.
    Byham-Gray L; Drasher T; Deckman K; Graham D; Liftman C; Roberto L; Peiffer P; Denmark R
    J Ren Nutr; 2009 Jul; 19(4):321-33. PubMed ID: 19464927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance.
    Durose CL; Holdsworth M; Watson V; Przygrodzka F
    J Am Diet Assoc; 2004 Jan; 104(1):35-41. PubMed ID: 14702581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a phosphorous educational program for dialysis patients.
    Prowant BF; Satalowich RJ; Murray-Bell A; Ryan LP; Schmidt LM; Kennedy JM; Baker BL
    ANNA J; 1989 Aug; 16(5):353-7. PubMed ID: 2774691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viewing an educational video can improve phosphorus control in patients on hemodialysis: a pilot study.
    Baldwin DM
    Nephrol Nurs J; 2013; 40(5):437-42; quiz 443. PubMed ID: 24308110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
    Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of water purification on renal osteodystrophy in the patients with regular hemodialysis therapy].
    Masuyama J; Tachibana Y
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):407-16. PubMed ID: 6471583
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.
    Sullivan C; Sayre SS; Leon JB; Machekano R; Love TE; Porter D; Marbury M; Sehgal AR
    JAMA; 2009 Feb; 301(6):629-35. PubMed ID: 19211470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional education for the management of osteodystrophy (nemo) in patients on haemodialysis: a randomised controlled trial.
    Karavetian M; Ghaddar S
    J Ren Care; 2013 Mar; 39(1):19-30. PubMed ID: 23176599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidimensional health locus of control as partial predictor of serum phosphorus in chronic hemodialysis.
    Schneider B
    Psychol Rep; 1992 Jun; 70(3 Pt 2):1171-4. PubMed ID: 1496090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
    Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
    J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensified diet education on serum phosphorus and knowledge of pediatric peritoneal dialysis patients.
    Abercrombie EL; Greenbaum LA; Baxter DH; Hopkins B
    J Ren Nutr; 2010 May; 20(3):193-8. PubMed ID: 20303791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal osteodystrophy in course of periodic dialysis for chronic uremia.
    Kim D; Bell NH; Bundesen W; Putong P; Simon NM; Walker C; Del Greco F
    Trans Am Soc Artif Intern Organs; 1968; 14():367-71. PubMed ID: 5701557
    [No Abstract]   [Full Text] [Related]  

  • 18. Understanding and managing hyperphosphatemia in patients with chronic renal disease.
    Malluche HH; Monier-Faugere MC
    Clin Nephrol; 1999 Nov; 52(5):267-77. PubMed ID: 10584989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiopathology of renal osteodystrophy. II. During chronic hemodialysis and after kidney transplantation].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Nov; 79(50):2291-6. PubMed ID: 4943105
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding the associations between modifying factors, individual health beliefs, and hemodialysis patients' adherence to a low-phosphorus diet.
    Elliott JO; Ortman C; Almaani S; Lee YH; Jordan K
    J Ren Nutr; 2015 Mar; 25(2):111-20. PubMed ID: 25282006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.